China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong · Delayed Price · Currency is HKD 4.990
+0.050 (1.01%)
Oct 28, 2025, 4:08 PM HKT
HKG:3320 Market Cap
HKG:3320 has a market cap or net worth of 31.35 billion as of October 29, 2025. Its market cap has decreased by -28.61% in one year.
Market Cap
31.35B
Enterprise Value
155.78B
Revenue
285.94B
Ranking
n/a
PE Ratio
10.22
Stock Price
4.99
Market Cap Chart
Since October 28, 2016, HKG:3320's market cap has decreased from 55.61B to 31.35B, a decrease of -43.63%. That is a compound annual growth rate of -6.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 28, 2025 | 31.35B | -12.46% |
| Dec 31, 2024 | 35.81B | 11.11% |
| Dec 29, 2023 | 32.23B | -18.83% |
| Dec 30, 2022 | 39.71B | 78.03% |
| Dec 31, 2021 | 22.30B | -10.80% |
| Dec 31, 2020 | 25.00B | -44.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 265.86B |
| Hansoh Pharmaceutical Group Company | 210.56B |
| JD Health International | 200.09B |
| WuXi Biologics | 147.39B |
| Innovent Biologics | 146.59B |
| Sino Biopharmaceutical | 124.42B |
| Akeso | 106.12B |
| Sichuan Kelun-Biotech Biopharmaceutical | 102.04B |